Humulin R 100 iu 10 ml
Humulin R (regular insulin) is a form of insulin used to treat diabetes. It is a short-acting insulin used to help control the spike in blood sugar that occurs after meals. It is typically used in combination with a long-acting insulin. Humulin R can also be used in an insulin pump. Humulin R (the standard insulin concentration) is available without a prescription, while U-500 Humulin R (a concentrated version used in special situations) requires a prescription.
Even though it is made in a laboratory, Humulin R is identical to the insulin produced by the human body. Insulin is a hormone that is naturally produced by the pancreas. This hormone is important for several functions, such as controlling blood sugar. Insulin helps the cells of your body remove glucose ("sugar") from your bloodstream. This sugar fuels your body's cells, giving them the energy they need to work properly. You may need to take insulin if your pancreas has trouble making enough insulin, which is the case in people with type 1 diabetes and in some people who have type 2 diabetes.
Humulin R is a short-acting insulin medication. It works more quickly than intermediate- or long-acting insulins but less quickly than rapid-acting insulins. It starts working relatively quickly, produces a peak in insulin levels, and drops off relatively quickly. It is designed to help control the blood sugar spike that occurs after meals. Most people who take Humulin R will also need a long-acting insulin as well, to provide a steady background level of insulin to help control blood sugar throughout the day.
Humulin R is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 and type 2 diabetes mellitus.
Humulin R when used subcutaneously, is usually given three or more times daily before meals. The dosage and timing of Humulin R should be individualized and determined, based on the physician's advice, in accordance with the needs of the patient. Humulin R may also be used in combination with oral antihyperglycemic agents or longer-acting insulin products to suit the needs of the individual patients with diabetes. The injection of Humulin R should be followed by a meal within approximately 30 minutes of administration.
The average range of total daily insulin requirement for maintenance therapy in insulin-treated patients without severe insulin resistance lies between 0.5 and 1 unit/kg/day. However, in pre-pubertal children it usually varies from 0.7 to 1 unit/kg/day, but can be much lower during the period of partial remission. In situations of insulin resistance, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for patients with diabetes are often lower, e.g., 0.2 to 0.4 units/kg/day.
Humulin R may be administered by subcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm. Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites. Injection into a lifted skin fold minimizes the risk of intramuscular injection. Injection sites should be rotated within the same region. As with all insulin, the duration of action will vary according to the dose, injection site, blood flow, temperature, and level of physical activity. For intravenous use, Humulin should be used at concentrations from 0.1 unit/mL to 1 unit/mL in infusion systems with the infusion fluids 0.9% sodium chloride using polyvinyl chloride infusion bags.
Humulin R is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Humulin R or any of its excipients.
Side effects: Hypoglycemia is one of the most frequent adverse events experienced by insulin users. Symptoms of mild to moderate hypoglycemia may occur suddenly and can include: sweating, dizziness, palpitation, tremor, hunger, restlessness, tingling in the hands, feet, lips, or tongue, lightheadedness, inability to oncentrate, headache.
No review yet
No questions yet